Levodopa-carbidopa subcutaneous infusion is helpful for Parkinson's disease.

Published Date: 17 Apr 2024

In Parkinson disease patients, subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without causing bothersome dyskinesia, according to a study published online in The Lancet Neurology on March 15.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

2.

Error on the MGUS-Autoimmune Disease Association.

3.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

4.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

5.

Unified Neuro/Psych Residency Program: New Proposal.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot